Sarah Palackdharry

452 total citations
17 papers, 312 citations indexed

About

Sarah Palackdharry is a scholar working on Oncology, Otorhinolaryngology and Molecular Biology. According to data from OpenAlex, Sarah Palackdharry has authored 17 papers receiving a total of 312 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 8 papers in Otorhinolaryngology and 6 papers in Molecular Biology. Recurrent topics in Sarah Palackdharry's work include Head and Neck Cancer Studies (8 papers), Cancer Immunotherapy and Biomarkers (8 papers) and Cancer Diagnosis and Treatment (4 papers). Sarah Palackdharry is often cited by papers focused on Head and Neck Cancer Studies (8 papers), Cancer Immunotherapy and Biomarkers (8 papers) and Cancer Diagnosis and Treatment (4 papers). Sarah Palackdharry collaborates with scholars based in United States. Sarah Palackdharry's co-authors include Trisha M. Wise‐Draper, Vinita Takiar, Shuchi Gulati, Roman Jandarov, Maria Lehn, Nooshin Hashemi Sadraei, Kathryn E. Aziz, Susan E. Waltz, Benjamin H. Hinrichs and Michelle Mierzwa and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Clinical Cancer Research.

In The Last Decade

Sarah Palackdharry

17 papers receiving 312 citations

Peers

Countries citing papers authored by Sarah Palackdharry

Since Specialization

Citations

This map shows the geographic impact of Sarah Palackdharry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah Palackdharry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah Palackdharry more than expected).

Fields of papers citing papers by Sarah Palackdharry

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah Palackdharry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah Palackdharry. The network helps show where Sarah Palackdharry may publish in the future.

Co-authorship network of co-authors of Sarah Palackdharry

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah Palackdharry. A scholar is included among the top collaborators of Sarah Palackdharry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah Palackdharry. Sarah Palackdharry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work	Indexed citations
1	Durvalumab plus Cetuximab in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: An Open-label, Nonrandomized, Phase II Clinical Trial 2023 ·Clinical Cancer Research ·Shuchi Gulati, (unknown), (unknown), Vinita Takiar, Maria Lehn, (unknown), Sarah Palackdharry, (unknown), Roman Jandarov, Nusrat Harun, Trisha M. Wise‐Draper	18
2	Metformin increases natural killer cell functions in head and neck squamous cell carcinoma through CXCL1 inhibition 2022 ·Journal for ImmunoTherapy of Cancer ·(unknown), (unknown), Sarah Palackdharry, Maria Lehn, Mario Medvedovic, (unknown), Shuchi Gulati, Vidhya Karivedu, Michael T. Borchers, (unknown), (unknown), Joseph Curry, Ubaldo Martinez‐Outschoorn, Vinita Takiar, Trisha M. Wise‐Draper	46
3	Glutaminase inhibition with telaglenastat (CB-839) improves treatment response in combination with ionizing radiation in head and neck squamous cell carcinoma models 2021 ·Cancer Letters ·(unknown), (unknown), Sunil Krishnan, Kathryn E. Aziz, (unknown), Sarah Palackdharry, (unknown), Trisha M. Wise‐Draper, Gordon B. Mills, Susan E. Waltz, Vinita Takiar	70
4	Association of pathological response to neoadjuvant pembrolizumab with tumor PD-L1 expression and high disease-free survival (DFS) in patients with resectable, local-regionally advanced, head and neck squamous cell carcinoma (HNSCC). 2021 ·Journal of Clinical Oncology ·Trisha M. Wise‐Draper, Vinita Takiar, Michelle Mierzwa, Keith Casper, Sarah Palackdharry, Francis P. Worden, Matthew Old, Neal Dunlap, John M. Kaczmar, Yash Patil, (unknown), (unknown), Ann M. Gillenwater, Benjamin H. Hinrichs, Diana Bell, (unknown), (unknown), Li Zhang, J. Jack Lee, Maura L. Gillison	20
5	Adjuvant nivolumab following salvage resection in head and neck squamous cell carcinoma patients previously treated with definitive therapy: A single-arm phase II multi-institutional study. 2021 ·Journal of Clinical Oncology ·Jennifer L. Leddon, Sulsal Haque, Shuchi Gulati, (unknown), Sarah Palackdharry, (unknown), Sarah M. Wilson, (unknown), (unknown), Vinita Takiar, Misako Nagasaka, Yash Patil, Chad Zender, Roman Jandarov, Alice L. Tang, Brian Cervenka, Li Zhang, Ammar Sukari, Trisha M. Wise‐Draper	2
6	Determining the molecular landscape and impact on prognosis in HPV-associated head and neck cancer 2020 ·PubMed ·(unknown), Sarah Palackdharry, (unknown), (unknown), (unknown), Zheng Zhu, (unknown), Alfredo Molinolo, Vinita Takiar, Trisha M. Wise‐Draper	8
7	PD1 blockade enhances K⁺ channel activity, Ca²⁺ signaling, and migratory ability in cytotoxic T lymphocytes of patients with head and neck cancer 2020 ·Journal for ImmunoTherapy of Cancer ·(unknown), Vaibhavkumar S. Gawali, Ameet A. Chimote, Maria Lehn, Sarah Palackdharry, Benjamin H. Hinrichs, Roman Jandarov, David A. Hildeman, Edith M. Janssen, Trisha M. Wise‐Draper, Laura Conforti	26
8	Intestinal B cells in the red‐eared slider turtle, Trachemys scripta: Anatomical distribution and implications for ecological interactions with pathogenic microbes 2019 ·Journal of Experimental Zoology Part A Ecological and Integrative Physiology ·(unknown), Sarah Palackdharry, Ben M. Sadd, Rachel M. Bowden, Laura A. Vogel	7
9	Phase 1 dose‐finding study of metformin in combination with concurrent cisplatin and radiotherapy in patients with locally advanced head and neck squamous cell cancer 2019 ·Cancer ·Shuchi Gulati, (unknown), Sarah Palackdharry, John C. Morris, Zheng Zhu, Roman Jandarov, (unknown), Vinita Takiar, Michelle Mierzwa, J. Silvio Gutkind, Alfredo Molinolo, Pankaj B. Desai, Nooshin Hashemi Sadraei, Trisha M. Wise‐Draper	37
10	Preliminary effects on the innate immune system with the combination of cetuximab and durvalumab in metastatic/ relapsed head and neck squamous cell carcinoma in a phase II trial. 2019 ·Journal of Clinical Oncology ·Shuchi Gulati, (unknown), (unknown), (unknown), Sarah Palackdharry, Vinita Takiar, Trisha M. Wise‐Draper	4
11	Metformin treatment of locally advanced head and neck squamous cell carcinoma (LAHNSCC) patients induces an anti-tumorigenic immune response. 2019 ·Journal of Clinical Oncology ·Vidhya Karivedu, (unknown), (unknown), Sarah Palackdharry, Shuchi Gulati, Roman Jandarov, Nooshin Hashemi Sadraei, Vinita Takiar, Trisha M. Wise‐Draper	3
12	A phase I dose-finding study of metformin in combination with concurrent cisplatin and radiation in patients with locally advanced head and neck squamous cell carcinoma. 2018 ·Journal of Clinical Oncology ·Shuchi Gulati, (unknown), Sarah Palackdharry, Vinita Takiar, Michelle Mierzwa, (unknown), John C. Morris, Changchun Xie, J. Silvio Gutkind, Pankaj B. Desai, Nooshin Hashemi Sadraei, Trisha M. Wise‐Draper	1
13	Metformin Induces Pro-Tumorigenic Cytokines And Natural Killer Cells In Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma 2018 ·International Journal of Radiation OncologyBiologyPhysics ·(unknown), Nooshin Hashemi Sadraei, Sarah Palackdharry, Vinita Takiar, Trisha M. Wise‐Draper	5
14	Phase II multi-site investigation of neoadjuvant pembrolizumab and adjuvant concurrent radiation and pembrolizumab with or without cisplatin in resected head and neck squamous cell carcinoma. 2018 ·Journal of Clinical Oncology ·Trisha M. Wise‐Draper, Matthew Old, Francis P. Worden, Paul E. O’Brien, Ezra E.W. Cohen, Neal Dunlap, Michelle Mierzwa, Keith Casper, Sarah Palackdharry, Benjamin H. Hinrichs, Alfredo A. Molinolo, Vinita Takiar, (unknown), Alice L. Tang, (unknown), John C. Morris, Nooshin Hashemi Sadraei, Changchun Xie, Maura L. Gillison	41
15	Gene expression signature after one dose of neoadjuvant pembrolizumab associated with tumor response in head and neck squamous cell carcinoma (HNSCC). 2018 ·Journal of Clinical Oncology ·Eejung Kim, Sarah Palackdharry, (unknown), (unknown), Alice L. Tang, Keith Wilson, Yash Patil, Edith M. Janssen, Laura Conforti, Vinita Takiar, Benjamin H. Hinrichs, Trisha M. Wise‐Draper	3
16	Decreased plasma DEK Oncogene Levels Correlate with p16-Negative Disease and Advanced Tumor Stage in a Case–Control Study of Patients with Head and Neck Squamous Cell Carcinoma 2017 ·Translational Oncology ·Trisha M. Wise‐Draper, (unknown), Sarah Palackdharry, (unknown), (unknown), (unknown), Nooshin Hashemi Sadraei, John C. Morris, Yash Patil, Keith Wilson, (unknown), Keith Casper, Vinita Takiar, Adam Lane, Lisa M. Privette Vinnedge	10
17	The effect of environmental temperature on reptilian peripheral blood B cell functions 2016 ·Hormones and Behavior ·Sarah Palackdharry, Ben M. Sadd, Laura A. Vogel, Rachel M. Bowden	11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact